News | June 14, 2026
Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
Samelisant will be the centerpiece of Suven’s scientific presence
Samelisant will be the centerpiece of Suven’s scientific presence
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The graduating cohort comprised seven batches across five specialized programs
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Targeting deadly drug-resistant acinetobacter infections
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Subscribe To Our Newsletter & Stay Updated
